Outset Medical (OM) Short-term Investments (2019 - 2026)

Outset Medical (OM) has 8 years of Short-term Investments data on file, last reported at $126.1 million in Q1 2026.

• Quarterly Short-term Investments rose 11.56% year-over-year to $126.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $126.1 million (up 11.56% YoY) and the FY2025 annual result came in at $133.9 million, up 286.32% from the prior year.
• Short-term Investments eased to $126.1 million in Q1 2026 per OM's latest filing, from $133.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $214.3 million in Q4 2022 and bottomed at $34.7 million in Q4 2024.
• The 5-year median for Short-term Investments is $157.0 million (2024), against an average of $154.9 million.
• The widest annual swing landed in 2022, when Short-term Investments soared 630.73%; it then slumped 74.28% in 2024.
• Tracing OM's Short-term Investments over 5 years: stood at $214.3 million in 2022, then slumped by 37.08% to $134.8 million in 2023, then tumbled by 74.28% to $34.7 million in 2024, then surged by 286.32% to $133.9 million in 2025, then decreased by 5.82% to $126.1 million in 2026.
• Per Business Quant, the three latest OM Short-term Investments figures stand at $126.1 million (Q1 2026), $133.9 million (Q4 2025), and $142.2 million (Q3 2025).

Peer Comparison